Cost-assessment of conditioning regimen in allogeneic haematopoietic stem cell transplantation using IV busulfan (Busilvex) versus oral busulfan:: a French model

被引：0
|
作者：
Esperou, H
Myon, E
Robin, M
Chadelat, C
Ferry, C
Devergie, A
Ribaud, P
Rocha, V
Socié, G
Gluckman, E
机构：
[1] E Gluckman Hop St Louis, Paris, France
[2] Pierre Fabra Grp, Boulogne, France
来源：
BONE MARROW TRANSPLANTATION | 2005年 / 35卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S224 / S224
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF IV BUSULFAN AND FLUDARABINE VS IV BUSULFAN AND CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN IN MYELOABALTIVE ALLOGENEIC STEM CELL TRANSPLANTATION
    de Villambrosia, S. Gonzalez
    Moreto, A.
    Nunez, J.
    Bermudez, A.
    Yanez, L.
    Insunza, A.
    Iriondo, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 142 - 142
  • [2] UK cost comparison of BuCy2 conditioning in allogeneic HSCT:: Oral versus IV busulfan (Busilvex®)
    Groves, LJ
    Hill, S
    Nichol, A
    Myon, E
    Orchard, KH
    VALUE IN HEALTH, 2005, 8 (06) : A126 - A126
  • [3] Intravenous busulfan as part of conditioning regimen in children undergoing allogeneic and autologous haematopoietic stem cell transplantation
    Gomez-Garcia, L.
    Molina, J. R.
    Rodriguez, G.
    Rodriguez-Villa, A.
    Garcia, E.
    Buenasmananas, D.
    Llamas, M. J.
    Chic, C.
    Rojas, R.
    Carmen, M.
    Gomez, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S265 - S265
  • [4] COST EFFECTIVENESS ANALYSIS OF BUSULFAN plus CYCLOPHOSPHAMIDE (BUCY2) AS CONDITIONING REGIMEN BEFORE ALLOGENEIC HUMAN STEAM CELL TRANSPLANTATION (HSCT): COMPARISON OF ORAL VERSUS IV BUSULFAN
    Tellez Giron, G.
    Salgado, J. L.
    Soto, H.
    VALUE IN HEALTH, 2012, 15 (04) : A220 - A220
  • [5] Once daily intravenous busulfan as part of a busulfan/cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation
    Mates, M
    Michalska, H
    Hasegawa, W
    Kiss, T
    Daly, A
    Loach, D
    Messner, H
    Lipton, J
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 36 - 36
  • [6] Conditioning with busulfan and fludarabine for allogeneic haematopoietic stem cell transplantation in children with acute myeloid leukaemia: a comparison to busulfan and cyclophosphamide
    Lee, S. H.
    Cheuh, H.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    Lee, J. W.
    Kim, H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S139 - S139
  • [7] ALLOGENEIC HAEMATOPOIETIC CELL TRANSPLANTATION USING INTRAVENOUS BUSULFAN IN MYELOABLATIVE AND REDUCED-INTENSITY CONDITIONING REGIMEN IN ACUTE LEUKEMIA PATIENTS. A COMPARISON ANALYSIS WITH ORAL BUSULFAN
    Sampol, A.
    Gutierrez, A.
    Ballester, C.
    Gual, C.
    Canaro, M.
    Novo, A.
    Galmes, A.
    Morey, M.
    Duran, M. A.
    Lo Rizzo, L.
    Besalduch, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S314 - S314
  • [8] Comparison of BuCy (Busulfan plus Cyclophosphamide) Versus FluBu4 (Fludarabine plus Busulfan) As a Conditioning Regimen for Allogeneic Stem Cell Transplantation
    Park, Silvia
    Hong, Jung Yong
    Choi, Moon Ki
    Kim, Young Saing
    Lee, Ji Yun
    Lim, Sung Hee
    Jung, Chul Won
    Jang, Jun Ho
    Kim, Kihyun
    BLOOD, 2012, 120 (21)
  • [9] Allogeneic hematopoietic stem cell transplantation using IV Busulfan.
    Arat, M
    Beksac, M
    Gurman, G
    Ozcan, M
    Arslan, O
    Soydan, E
    Yazman, D
    Topcuoglu, P
    Ilhan, O
    Koc, H
    Uysal, A
    Konuk, N
    Akan, H
    BLOOD, 2001, 98 (11) : 342B - 342B
  • [10] Alpha n intravenous busulfan based myeloablative conditioning regimen for allogeneic haematopoietic stem cell transplantation in paediatric ALL patients
    Paisiou, A.
    Peristeri, I.
    Kitra, V.
    Vessalas, G.
    Dimopoulou, M.
    Graphakos, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S103 - S103
12345